- Home
- SNGX vs ELWS Comparison
SNGX vs ELWS Comparison
Compare SNGX & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- ELWS
- Stock Information
- Founded
- SNGX 1987
- ELWS 2018
- Country
- SNGX United States
- ELWS Japan
- Employees
- SNGX N/A
- ELWS N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- ELWS
- Sector
- SNGX Health Care
- ELWS
- Exchange
- SNGX Nasdaq
- ELWS Nasdaq
- Market Cap
- SNGX 6.5M
- ELWS 6.1M
- IPO Year
- SNGX 1987
- ELWS 2023
- Fundamental
- Price
- SNGX $1.36
- ELWS $2.49
- Analyst Decision
- SNGX Strong Buy
- ELWS
- Analyst Count
- SNGX 1
- ELWS 0
- Target Price
- SNGX $6.00
- ELWS N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- ELWS 3.2M
- Earning Date
- SNGX 08-08-2025
- ELWS 07-29-2025
- Dividend Yield
- SNGX N/A
- ELWS N/A
- EPS Growth
- SNGX N/A
- ELWS N/A
- EPS
- SNGX N/A
- ELWS N/A
- Revenue
- SNGX $2,342.00
- ELWS $3,069,669.00
- Revenue This Year
- SNGX N/A
- ELWS N/A
- Revenue Next Year
- SNGX N/A
- ELWS N/A
- P/E Ratio
- SNGX N/A
- ELWS N/A
- Revenue Growth
- SNGX N/A
- ELWS 144.46
- 52 Week Low
- SNGX $1.09
- ELWS $1.04
- 52 Week High
- SNGX $7.20
- ELWS $8.68
- Technical
- Relative Strength Index (RSI)
- SNGX 44.21
- ELWS 53.96
- Support Level
- SNGX $1.24
- ELWS $2.35
- Resistance Level
- SNGX $1.40
- ELWS $2.68
- Average True Range (ATR)
- SNGX 0.14
- ELWS 0.40
- MACD
- SNGX 0.03
- ELWS -0.02
- Stochastic Oscillator
- SNGX 34.18
- ELWS 45.74
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.